Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Jin Long Chen | Chief Scientific Officer, Director | $1.3M | Mar 2, 2023 | ||
Mangini Siobhan Nolan | President and CFO | $102K | Mar 2, 2023 | ||
Column Group L P | Director, 10%+ Owner | $1.34K | Apr 5, 2024 | ||
TCG Opportunity III GP, LLC | 10%+ Owner | $1.34K | Apr 5, 2024 | ||
Column Group Gp, Lp | 10%+ Owner | $1.34K | Apr 5, 2024 | ||
David V. Goeddel | Director, 10%+ Owner | $1.34K | Apr 5, 2024 | ||
Suzanne Sawochka Hooper | Director | $0 | Apr 5, 2024 | ||
Hsiao D. Lieu | Chief Medical Officer | $0 | Apr 5, 2024 | ||
David J. Woodhouse | Chief Executive Officer, Director | $0 | Apr 5, 2024 | ||
Irene Perlich | Principal Accounting Officer | $0 | Apr 5, 2024 | ||
Valerie Pierce | General Counsel, Chief Compliance Officer and Secretary | $0 | Mar 26, 2024 | ||
William Jl Rieflin | Director | $0 | Apr 5, 2024 | ||
Jean-Frederic Viret | Chief Financial Officer | $0 | Mar 26, 2024 | ||
Carole Ho | Director | Apr 5, 2024 | |||
Roger M. Perlmutter | Director | Apr 5, 2024 | |||
Mark Leschly | Director | Jun 8, 2021 | |||
Shelly D. Guyer | Director | Apr 5, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|